# FDA Inspection 765625 - American National Red Cross - February 01, 2012

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/9b7aa65b-f29c-42b4-9272-4f18f04cfa45
Source feed: FDA_Inspections

> FDA Inspection 765625 for American National Red Cross on February 01, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 765625
- Company Name: American National Red Cross
- Inspection Date: 2012-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262045 - 2025-01-28](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/eb491141-49b6-4ea1-a97d-9a703d7abc7e)
- [FDA Inspection 1262045 - 2025-01-28](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/f8b7c02b-7733-46fd-ab75-0013ed0e7898)
- [FDA Inspection 1146850 - 2021-06-22](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/cf4f952e-0548-4e81-9a2e-ee023cb25547)
- [FDA Inspection 1029208 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/1b1fcb6d-7c7e-4b1c-afdc-ac12003c6689)
- [FDA Inspection 951323 - 2015-11-16](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/3d280a96-6b48-4996-b4f3-bd238e66e715)

Company: https://www.keypedia.com/companies/american-national-red-cross/6ad66bf9-a03b-40f2-b5f3-4a3289c5a8ce

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d